Emmanouil Charitakis

Publications
Public outreach and news

Articles

Article: HEART RHYTHM. 2026;:S1547-5271(25)03164-9
Marshall-plan ablation strategy for recurrent persistent atrial fibrillation in patients with durably isolated pulmonary veins.
Åkerström F; Charitakis E; Paul-Nordin A; Saygi S; Svennberg E; Braunschweig F; Jensen-Urstad M; Drca N
Journal article: EUROPEAN HEART JOURNAL: DIGITAL HEALTH. 2026;7(1):ztaf110
Artificial intelligence-enabled electrocardiographic 'sex discrepancy' as a predictor of atrial fibrillation recurrence: contextualising the findings of park et al.
Pantelidis P; Charitakis E; Oikonomou E
Journal article: JOURNAL OF PHYSIOLOGY-LONDON. 2025
Computational model of haemodynamics during atrial fibrillation
Plappert F; Oomen PJA; Jones CE; Charitakis E; Karlsson LO; Platonov PG; Wallman M; Sandberg F
Article: HEART. 2025;:heartjnl-2025-325926
Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses
Kylhammar A; Tsartsalis D; Hijazi Z; Aggeli C; Tsioufis C; Karlsson LO; Venetsanos D; Braunschweig F; Drca N; Paul-Nordin A; Akerstrom F; Svennberg E; Charitakis E
Journal article: EUROPEAN HEART JOURNAL: DIGITAL HEALTH. 2025;6(5):997-1005
Cost-effectiveness of a clinical decision support system for atrial fibrillation: an RCT-based modelling study
Persson Lindell O; Henriksson M; Karlsson LO; Nilsson S; Charitakis E; Janzon M
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2025;12:1639305
Incidence of atrial fibrillation and its association with long-term outcome in patients with an accessory pathway
von Olshausen G; Schwieler J; Bastani H; Bourke T; Saluveer O; Drca N; Paul-Nordin A; Charitakis E; Asaad F; Saygi S; Turkmen Y; Svennberg E; Akerstrom F; Jensen-Urstad M; Braunschweig F
Journal article: EUROPEAN HEART JOURNAL OPEN. 2025;5(5):oeaf089
Differences in inflammation biomarkers between patients with paroxysmal and persistent atrial fibrillation in the femoral vein and coronary sinus blood samples; a cohort study
Valera Soria C; Carlhall C-J; Karlsson LO; Lindback J; Hijazi Z; Charitakis E
Journal article: EUROPEAN HEART JOURNAL OPEN. 2025;5(4):oeaf085
Cutting into the storm: timing, benefits, and risks of ventricular tachycardia ablation across different arrhythmia substrates
Braunschweig F; Charitakis E; Akerstrom F; Drca N
Journal article: EUROPACE. 2025;27(Supplement_1):euaf085.492
Evaluation of an Internet-based educational programme in patients with atrial fibrillation (ASK FOR IT)
Sandgren E; Charitakis E; Walfridsson H; Walfridsson U
Journal article: EUROPACE. 2025;27(4):euaf032
PULSE survey: Population Survey on Knowledge, Gaps and Perception of Heart Rhythm disorders-an initiative of the Scientific Initiatives Committee of the European Heart Rhythm Association
Gunawardene MA; Puererfellner H; Merino JL; Linz D; Sultan A; Scherr D; Deharo JC; Wohlmuth P; Feldhege J; Costa FM; Ribeiro S; Charitakis E; Verstrael A; Anselmino M; Szeplaki G; Simovic S; Jadczyk T; Adelino R; Katsoularis I; Liebregts M; Tilz RR; Chun K-RJ
Journal article: EUROPEAN HEART JOURNAL OPEN. 2025;5(2):oeaf037
Individually designed ablation of low-voltage areas in persistent atrial fibrillation-a randomized controlled trial (IDEAL-AF): study design and rationale
Paul Nordin A; Jensen-Urstad M; Charitakis E; Akerstrom F; Almroth H; Herczku C; Tapanainen J; Hoglund N; Drca N
Article: HEART RHYTHM. 2024;21(9):1487-1492
Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation
Akerstrom F; Charitakis E; Paul-Nordin A; Braunschweig F; Friberg L; Tabrizi F; Jensen-Urstad M; Drca N
Article: HEART RHYTHM O2. 2024;5(6):351-356
Symptoms of gastroesophageal reflux disease predicts low voltage zones in the posteroinferior left atrium in patients with persistent atrial fibrillation
Nordin AP; Charitakis E; Carnlo C; Aerstrom F; Drca N
Article: JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2024;35(6):1140-1149
Predictors of low-voltage zones in patients with persistent atrial fibrillation eligible for catheter ablation: An observational study
Nordin AP; Jensen-Urstad M; Charitakis E; Carnloef C; Drca N
Article: HEART. 2024;110(3):163-169
Association between catheter ablation of atrial fibrillation and mortality or stroke
Akerstrom F; Hutter J; Charitakis E; Tabrizi F; Asaad F; Bastani H; Bourke T; Braunschweig F; Drca N; Englund A; Friberg L; Insulander P; Jonsson AH; Kenneback G; Paul-Nordin A; Sadigh B; Saluveer O; Saygi S; Schwieler J; Svennberg E; Tapanainen J; Turkmen Y; Jensen-Urstad M
Journal article: EUROPEAN HEART JOURNAL OPEN. 2023;3(6):oead126
Response to Kataoka et al.'s 'How to assess haemodynamic impact of atrial fibrillation'
Almroth H; Karlsson LO; Carlhall C-J; Charitakis E
Journal article: EUROPEAN HEART JOURNAL OPEN. 2023;3(6):oead112
Haemodynamic changes after atrial fibrillation initiation in patients eligible for catheter ablation: a randomized controlled study
Almroth H; Karlsson LO; Carlhall C-J; Charitakis E
Journal article: EUROPACE. 2023;25(Supplement_1):euad122.112
Catheter ablation of atrial fibrillation is associated with reduced mortality in real-world swedish patients
Akerstrom F; Hutter J; Charitakis E; Tabrizi F; Drca N; Friberg L; Braunschweig F; Jensen-Urstad M
Journal article: EUROPACE. 2023;25(Supplement_1):euad122.306
Effect of ventricular tachycardia ablation on symptoms and health-related quality of life: data from a single-center registry
Charitakis E; Soria CV; Almroth H; Karlsson L; Guidi C; Sandgren E; Liuba I; Balata D; Jonsson AH; Walfridsson H; Walfridsson U
Journal article: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY. 2023;66(2):483
Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience (Sept, pg 1, 2022)
Archontakis S; Oikonomou E; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
Journal article: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY. 2023;66(2):471-481
Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience
Archontakis S; Oikonomou EK; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
Journal article: EUROPACE. 2023;25(1):40-48
Predictors of recurrence after catheter ablation and electrical cardioversion of atrial fibrillation: an umbrella review of meta-analyses
Charitakis E; Dragioti E; Stratinaki M; Korela D; Tzeis S; Almroth H; Liuba I; Jonsson AH; Charalambous G; Karlsson LO; Tsartsalis D
Journal article: OPEN HEART. 2022;9(2):e002074
Risk and protective factors for atrial fibrillation after cardiac surgery and valvular interventions: an umbrella review of meta-analyses
Charitakis E; Tsartsalis D; Korela D; Stratinaki M; Vanky F; Charitos EI; Alfredsson J; Karlsson LO; Foukarakis E; Aggeli C; Tsioufis C; Walfridsson H; Dragioti E
Article: BMC MEDICINE. 2022;20(1):193
Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: a network meta-analysis
Charitakis E; Metelli S; Karlsson LO; Antoniadis AP; Rizas KD; Liuba I; Almroth H; Jonsson AH; Schwieler J; Tsartsalis D; Sideris S; Dragioti E; Fragakis N; Chaimani A
Journal article: AMERICAN HEART JOURNAL. 2022;247:132-148
Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care
Lindell OP; Karlsson LO; Nilsson S; Charitakis E; Hagstrom E; Muhr T; Nilsson L; Henriksson M; Janzon M
Article: CLINICAL CARDIOLOGY. 2022;45(1):42-50
Symptoms and health-related quality of life 5 years after catheter ablation of atrial fibrillation
Walfridsson U; Hassel Jonsson A; Karlsson LO; Liuba I; Almroth H; Sandgren E; Walfridsson H; Charitakis E
Journal article: JOURNAL OF ATRIAL FIBRILLATION. 2021;14(1):20200454
Endocrine and Mechanical Cardiacfunction Four Months after Radiofrequency Ablation of Atrialfibrillation.
Charitakis E; OKarlsson L; Carlhäll C-J; Liuba I; Jönsson AH; Walfridsson H; Alehagen U
Journal article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2021;10(Supplement_1):zuab020.104
Is HBA1C reliable in diagnosing diabetes in the acute phase of acute coronary syndromes?
Stratinaki M; Milaki K; Stavrakis S; Pitarokoilis M; Charitakis E; Stavratis S; Kafarakis P; Garidas G; Korela D; Katsiavos A; Thanasia A; Rogdakis E; Lamprogiannakis E; Foukarakis E
Journal article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2021;10(Supplement_1):zuab020.041
Prevalence of undiagnosed pre-diabetes or diabetes in patients with HFpEF presenting in the emergency department
Stratinaki M; Milaki K; Stavrakis S; Pitarokoilis M; Rogdakis E; Charitakis E; Kafarakis P; Garidas G; Stavratis S; Korela D; Katsiavos A; Thanasia A; Lamprogiannakis E; Foukarakis E
Article: JACC-CARDIOVASCULAR INTERVENTIONS. 2021;14(7):754-763
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
Venetsanos D; Skibniewski M; Janzon M; Lawesson SS; Charitakis E; Bohm F; Henareh L; Andell P; Karlson LO; Simonsson M; Volz S; Erlinge D; Omerovic E; Alfredsson J
Journal article: TRANSLATIONAL MEDICINE COMMUNICATIONS. 2020;5(1):11
Biochemical response to cryothermal and radiofrequency exposure of the human myocardium at surgical ablation of atrial fibrillation: a randomized controlled trial
Boano G; Aneq MÅ; Spyrou G; Enocsson H; Charitakis E; Vánky F
Journal article: BMJ OPEN. 2020;10(11):e041819
Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: protocol of a network meta-analysis of randomised controlled trials
Charitakis E; Karlsson LO; Rizas K; Almroth H; Jonsson AH; Schweiler J; Sideris S; Tsartsalis D; Dragioti E; Chaimani A
Journal article: EUROPEAN HEART JOURNAL. 2020;41(Supplement_2):ehaa946.0602
Five year follow-up of symptoms and health-related quality of life in patients with atrial fibrillation treated with catheter ablation
Walfridsson U; Jonsson AH; Karlsson LO; Almroth H; Liuba I; Walfridsson H; Charitakis E
Journal article: LAKARTIDNINGEN. 2020;117:FYT3
[Evaluation and treatment of PVC's].
Sandgren E; Almroth H; O Karlsson L; Hassel Jönsson A; Walfridsson H; Charitakis E; Liuba I
Journal article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2020;43(1):157
Gender and age differences in symptoms and health-related quality of life in patients with atrial fibrillation referred for catheter ablation
Walfridsson U; Hansen PS; Charitakis E; Almroth H; Jonsson A; Karlsson LO; Liuba I; Ayou RS; Poci D; Holmqvist F; Kongstad O; Walfridsson H
Journal article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2019;42(11):1431-1439
Gender and age differences in symptoms and health-related quality of life in patients with atrial fibrillation referred for catheter ablation
Walfridsson U; Hansen PS; Charitakis E; Almroth H; Jonsson A; Karlsson LO; Liuba I; Ayou RS; Poci D; Holmqvist F; Kongstad O; Walfridsson H
Journal article: FRONTIERS IN PHYSIOLOGY. 2019;10:1215
Echocardiographic and Biochemical Factors Predicting Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation-An Observational Study
Charitakis E; Karlsson LO; Papageorgiou J-M; Walfridsson U; Carlhall C-J
Journal article: PLOS ONE. 2019;14(4):e0215121
The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation
Barmano N; Charitakis E; Kronstrand R; Walfridsson U; Karlsson J-E; Walfridsson H; Nystrom FH
Journal article: CLINICAL CARDIOLOGY. 2019;42(2):247-255
Predictors of improvement in arrhythmia-specific symptoms and health-related quality of life after catheter ablation of atrial fibrillation
Barmano N; Charitakis E; Karlsson J-E; Nystrom FH; Walfridsson H; Walfridsson U
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy563.p4830
P4830Neurohormonal and echocardiographic predictors of recurrence of atrial fibrillation following radiofrequency ablation
Charitakis E; Karlsson L; Carlhall C-J; Walfridsson U; Walfridsson H
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy563.p3831
P3831Still neuroendocrine effects 4 months after radiofrequency ablation of atrial fibrillation
Charitakis E; Alehagen U; Walfridsson H
Journal article: PLOS MEDICINE. 2018;15(3):e1002528
A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)
Karlsson LO; Nilsson S; Bang M; Nilsson L; Charitakis E; Janzon M
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.p3602
P3602Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): a cluster randomized trial in the primary care setting
Karlsson LO; Nilsson S; Charitakis E; Nilsson L; Janzon M
Journal article: EUROPACE. 2017;19(suppl_3):iii62
P353Predictors of recurrence after radiofrequency ablation of atrial fibrillation
Charitakis E; Walfridsson H; Alehagen U
Journal article: JACC-CLINICAL ELECTROPHYSIOLOGY. 2017;3(5):494-502
Factors Predicting Arrhythmia-Related Symptoms and Health-Related Quality of Life in Patients Referred for Radiofrequency Ablation of Atrial Fibrillation: An Observational Study (the SMURF Study).
Charitakis E; Barmano N; Walfridsson U; Walfridsson H
Journal article: AMERICAN HEART JOURNAL. 2017;187:45-52
Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): Rationale and design of a cluster randomized trial in the primary care setting
Karlsson LO; Nilsson S; Charitakis E; Bang M; Johansson G; Nilsson L; Janzon M
Journal article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2016;5(12):e003957
Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study
Charitakis E; Walfridsson H; Nylander E; Alehagen U
Journal article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2016;5(9):e003557
Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study
Charitakis E; Walfridsson A; Alehagen U
Journal article: BMJ OPEN. 2015;5(12):e008723
Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised interventional component
Charitakis E; Walfridsson U; Nystrom F; Nylander E; Stromberg A; Alehagen U; Walfridsson H
Show more

All other publications

Preprint: BIORXIV. 2025
A computational model to study hemodynamics during atrial fibrillation
Plappert F; Oomen PJA; Jones C; Charitakis E; Karlsson L; Platonov P; Wallman M; Sandberg F
Review: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2022;9:848021
Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses
Tsartsalis D; Korela D; Karlsson LO; Foukarakis E; Svensson A; Anastasakis A; Venetsanos D; Aggeli C; Tsioufis C; Braunschweig F; Dragioti E; Charitakis E
Review: DIAGNOSTICS. 2022;12(2):433
Comparing Efficacy and Safety in Catheter Ablation Strategies for Paroxysmal Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials
Charitakis E; Metelli S; Karlsson LO; Antoniadis AP; Liuba I; Almroth H; Jonsson AH; Schwieler J; Sideris S; Tsartsalis D; Dragioti E; Fragakis N; Chaimani A
Preprint: RESEARCH SQUARE. 2020
Biochemical response to cryothermal and radiofrequency exposure of the human myocardium at surgical ablation of atrial fibrillation: a randomized controlled trial.
Boano G; Aneq MÅ; Spyrou G; Enocsson H; Emmanouil C; Vánky F
Preprint: RESEARCH SQUARE. 2020
Biochemical response to cryothermal and radiofrequency exposure of the human myocardium at surgical ablation of atrial fibrillation: a randomized controlled trial.
Boano G; Aneq MÅ; Spyrou G; Enocsson H; Emmanouil C; Vánky F
Conference publication: CIRCULATION. 2018;138
Predictors of Improvement in Arrhythmia-Specific Symptoms and Health-Related Quality of Life After Catheter Ablation of Atrial Fibrillation
Barmano N; Charitakis E; Karlsson J-E; Nystrom FH; Walfridsson H; Walfridsson U
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:1017
Neurohormonal and echocardiographic predictors of recurrence of atrial fibrillation following radiofrequency ablation
Charitakis E; Karlsson L; Carlhall C-J; Walfridsson U; Walfridsson H
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:772
Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): a cluster randomized trial in the primary care setting
Karlsson LO; Nilsson S; Charitakis E; Nilsson L; Janzon M

Articles

All other publications

News from KI

Events from KI